Bio-Techne (TECH) Fundamental Analysis: Revenue, Earnings & Valuation

9.51 / 10

Outperform

Fundamentally the company shines on PB‑ROE, Net‑income‑Revenue and Cash‑UP, each receiving high quality scores. Asset‑MV and Cost‑of‑Sales are weaker, dragging performance. Overall the fundamental composite is strong, supporting the Outperform rating despite some efficiency gaps.

Analysis Checks(6/10)

Profit-MV

Value-0.92

Score1/3

Weight-14.51%

1M Return-0.79%

Net income-Revenue

Value-0.04

Score3/3

Weight103.37%

1M Return4.11%

PB-ROE

Value2.57

Score2/3

Weight29.76%

1M Return1.39%

Current assets turnover ratio

Value1.99

Score1/3

Weight-5.30%

1M Return-0.27%

Cash-UP

Value0.60

Score3/3

Weight59.57%

1M Return2.87%

Total assets turnover ratio

Value0.46

Score3/3

Weight31.37%

1M Return1.82%

Cost of sales ratio (%)

Value35.20

Score1/3

Weight-13.70%

1M Return-0.80%

Asset-MV

Value-1.23

Score2/3

Weight-15.79%

1M Return-0.95%

Inventory turnover days

Value154.77

Score2/3

Weight-6.91%

1M Return-0.39%

Cash-MV

Value-0.80

Score1/3

Weight-67.85%

1M Return-3.18%

Is TECH fundamentally strong?

TECH scores 9.51/10 on fundamentals and holds a Discounted valuation at present. Backed by its 3.88% ROE, 6.67% net margin, 101.72 P/E ratio, 4.10 P/B ratio, and -47.00% earnings growth, these metrics solidify its Outperform investment rating.